These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study. Chan HW; Huang CY; Feng WJ; Yen YC Psychiatry Clin Neurosci; 2015 Aug; 69(8):497-503. PubMed ID: 25781185 [TBL] [Abstract][Full Text] [Related]
5. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens. Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related]
7. Long-acting injectable risperidone. Ehret MJ; Fuller MA Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979 [TBL] [Abstract][Full Text] [Related]
8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
9. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Bhanji NH; Chouinard G; Margolese HC Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023 [TBL] [Abstract][Full Text] [Related]
10. Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission. Liu CC; Chiang HL; Wu SY CNS Drugs; 2008; 22(3):257-8. PubMed ID: 18278979 [No Abstract] [Full Text] [Related]
11. Clinical review of a long-acting, injectable formulation of risperidone. Knox ED; Stimmel GL Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study. Barrio P; Batalla A; CastellvĂ P; Hidalgo D; GarcĂa M; Ortiz A; Grande I; Pons A; Parellada E Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone. Martin SD; Libretto SE; Pratt DJ; Brewin JS; Huq ZU; Saleh BT Curr Med Res Opin; 2003; 19(4):298-305. PubMed ID: 12841922 [TBL] [Abstract][Full Text] [Related]
14. Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia. Lauriello J; McEvoy JP; Rodriguez S; Bossie CA; Lasser RA Schizophr Res; 2005 Jan; 72(2-3):249-58. PubMed ID: 15560969 [TBL] [Abstract][Full Text] [Related]
15. Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. Kim E; Correll CU; Mao L; Starr HL; Alphs L CNS Spectr; 2016 Dec; 21(6):466-477. PubMed ID: 27629292 [TBL] [Abstract][Full Text] [Related]
16. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population. Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690 [TBL] [Abstract][Full Text] [Related]
17. New for old? Risperidone long-acting injection in older patients. Hudson-Jessop P; Hughes B; Brinkley N Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255 [TBL] [Abstract][Full Text] [Related]
18. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial. Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752 [TBL] [Abstract][Full Text] [Related]
19. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia. Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH; Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143 [TBL] [Abstract][Full Text] [Related]
20. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. Dursun S J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780 [No Abstract] [Full Text] [Related] [Next] [New Search]